Using immunohistochemical analysis, which routinely evaluates the expression of the endocrine receptors (estrogen receptor (ER) and progesterone receptor (PR) and human epidermal growth factor-2 (HER2), breast cancer is further classified into five molecular subtypes [7,8]. Here, ERBB2 is linked to breast carcinoma.